Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Thyroid Cancer, Papillary 1Sarcoma 1Pancreatic carcinoma, familial 1Pancreatic Intraductal Neoplasms 1Glioma 1Glioblastoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Medullary 1Cancer of Lymph Node 1Brain Neoplasms 1Adult Brain Glioblastoma 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 27Dexmedetomidine 8Radiotherapy 7Radiation 7Proton Therapy 7Mental Status and Dementia Tests 7Magnetic Resonance Imaging 7Exercise 6Surgical Procedures, Operative 5Specimen Handling 5Saline Solution 5Blood Specimen Collection 5Bevacizumab 5Remifentanil 4Radiotherapy, Intensity-Modulated 4Propofol 4alovudine 3Transcranial Magnetic Stimulation 3Temozolomide 3Resistance Training 3Methods 3Mannitol 3Diffusion Tensor Imaging 3Cognitive Training 3gadobutrol 2gadobenic acid 2Yoga 2Vitamin D 2Ultrasonography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Brain Neoplasms × Ferrosoferric Oxide × Clear all
NCT00103038 2022-06-09

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

OHSU Knight Cancer Institute

Phase NA Completed
155 enrolled 11 charts
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡